Whole Genome/Whole Exome

Comprehensive Genome-scale Sequencing

Overview

Whole genome and whole exome sequencing for broad cancer variant discovery and precision oncology.

Why this Test Matters

Precision oncology depends on identifying clinically actionable genomic alterations. This assay helps clinicians select targeted therapies, evaluate immunotherapy eligibility, identify prognostic biomarkers, detect resistance mechanisms, and match patients to suitable clinical trials while minimizing sequential testing.

Who Should Consider this Test?

● Rare cancers
● Research
● Negative targeted panels

Applicable Cancer Types

All cancers

What is Covered?

  • WGS
  • WES
  • Coding variants
  • CNVs
  • SVs
  • Mitochondrial variants

Clinical Utility​

  • Treatment selection
  • Prognostic and predictive biomarkers
  • Clinical trial matching
  • Identification of actionable alterations
  • Comprehensive clinical interpretation

Technology

Short-read clinical sequencing

key Features

Parameter Details
Sample Type
Tumor + matched normal
Samples
Tumor ± blood
Turnaround Time
~21 working days
Report Includes
Variant interpretation, therapy associations, clinically actionable biomarkers
Quality
High-depth NGS with rigorous QC